The histone demethylase KDM5A is a key factor for the resistance to temozolomide in glioblastoma
出版年份 2015 全文链接
标题
The histone demethylase KDM5A is a key factor for the resistance to temozolomide in glioblastoma
作者
关键词
-
出版物
CELL CYCLE
Volume 14, Issue 21, Pages 3418-3429
出版商
Informa UK Limited
发表日期
2015-11-14
DOI
10.1080/15384101.2015.1090063
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- A transcriptomic signature mediated by HOXA9 promotes human glioblastoma initiation, aggressiveness and resistance to temozolomide
- (2015) Marta Pojo et al. Oncotarget
- Temozolomide resistance in glioblastoma occurs by miRNA-9-targeted PTCH1, independent of sonic hedgehog level
- (2015) Jessian L. Munoz et al. Oncotarget
- Targeting miR-381-NEFL axis sensitizes glioblastoma cells to temozolomide by regulating stemness factors and multidrug resistance factors
- (2015) Zeyou Wang et al. Oncotarget
- KDM1 is a novel therapeutic target for the treatment of gliomas
- (2015) Gangadhara R Sareddy et al. Oncotarget
- Reduction of MLH1 and PMS2 confers temozolomide resistance and is associated with recurrence of glioblastoma
- (2015) Yoshinari Shinsato et al. Oncotarget
- EFEMP1 induces γ-secretase/Notch-mediated temozolomide resistance in glioblastoma
- (2015) Lotte Hiddingh et al. Oncotarget
- Metformin repositioning as antitumoral agent: selective antiproliferative effects in human glioblastoma stem cells, via inhibition of CLIC1-mediated ion current
- (2015) Marta Gritti et al. Oncotarget
- The Effects of Histone Deacetylase Inhibitors on Glioblastoma-Derived Stem Cells
- (2014) Angel A. Alvarez et al. JOURNAL OF MOLECULAR NEUROSCIENCE
- Histone deacetylase inhibitors in glioblastoma: pre-clinical and clinical experience
- (2014) Pavel Bezecny MEDICAL ONCOLOGY
- The Changes in MGMT Promoter Methylation Status in Initial and Recurrent Glioblastomas
- (2014) Chul-Kee Park et al. Translational Oncology
- Epigenetic modulation of the drug resistance genes MGMT, ABCB1 and ABCG2 in glioblastoma multiforme
- (2013) Moritz C Oberstadt et al. BMC CANCER
- Overcoming Intrinsic Multidrug Resistance in Melanoma by Blocking the Mitochondrial Respiratory Chain of Slow-Cycling JARID1Bhigh Cells
- (2013) Alexander Roesch et al. CANCER CELL
- Sorafenib selectively depletes human glioblastoma tumor-initiating cells from primary cultures
- (2013) Elisa Carra et al. CELL CYCLE
- Chromatin proteins and modifications as drug targets
- (2013) Kristian Helin et al. NATURE
- Temozolomide downregulates P-glycoprotein expression in glioblastoma stem cells by interfering with the Wnt3a/glycogen synthase-3 kinase/ -catenin pathway
- (2013) C. Riganti et al. NEURO-ONCOLOGY
- Clinical Potentials of Methylator Phenotype in Stage 4 High-Risk Neuroblastoma: An Open Challenge
- (2013) Barbara Banelli et al. PLoS One
- Inhibition of CXCL12/CXCR4 autocrine/paracrine loop reduces viability of human glioblastoma stem-like cells affecting self-renewal activity
- (2013) Monica Gatti et al. TOXICOLOGY
- Metformin selectively affects human glioblastoma tumor-initiating cell viability
- (2012) Roberto Würth et al. CELL CYCLE
- Inhibition of Histone Deacetylation Potentiates the Evolution of Acquired Temozolomide Resistance Linked to MGMT Upregulation in Glioblastoma Xenografts
- (2012) G. J. Kitange et al. CLINICAL CANCER RESEARCH
- Epigenomics and Interindividual Differences in Drug Response
- (2012) M Ivanov et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- The status of the art of human malignant glioma management: the promising role of targeting tumor-initiating cells
- (2012) Tullio Florio et al. DRUG DISCOVERY TODAY
- Molecular mechanisms of temozolomide resistance in glioblastoma multiforme
- (2012) Tor-Christian Aase Johannessen et al. Expert Review of Anticancer Therapy
- Emerging insights into the molecular and cellular basis of glioblastoma
- (2012) G. P. Dunn et al. GENES & DEVELOPMENT
- The UCSC Cancer Genomics Browser: update 2013
- (2012) Mary Goldman et al. NUCLEIC ACIDS RESEARCH
- Glioma Stem Cells: Their Role in Chemoresistance
- (2012) Ryosuke Yamada et al. World Neurosurgery
- Inhibitors of histone demethylation and histone deacetylation cooperate in regulating gene expression and inhibiting growth in human breast cancer cells
- (2011) Yi Huang et al. BREAST CANCER RESEARCH AND TREATMENT
- Quantitative methylation analysis of HOXA3, 7, 9, and 10 genes in glioma: association with tumor WHO grade and clinical outcome
- (2011) Angela Di Vinci et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- A pyrosequencing assay for the quantitative methylation analysis of the PCDHB gene cluster, the major factor in neuroblastoma methylator phenotype
- (2011) Barbara Banelli et al. LABORATORY INVESTIGATION
- O6-methylguanine DNA-methyltransferase methylation status can change between first surgery for newly diagnosed glioblastoma and second surgery for recurrence: clinical implications
- (2011) A. A. Brandes et al. NEURO-ONCOLOGY
- Drug-Tolerant Cancer Cells Show Reduced Tumor-Initiating Capacity: Depletion of CD44+ Cells and Evidence for Epigenetic Mechanisms
- (2011) Hong Yan et al. PLoS One
- Identification of a CpG Island Methylator Phenotype that Defines a Distinct Subgroup of Glioma
- (2010) Houtan Noushmehr et al. CANCER CELL
- Reversing HOXA9 Oncogene Activation by PI3K Inhibition: Epigenetic Mechanism and Prognostic Significance in Human Glioblastoma
- (2010) B. M. Costa et al. CANCER RESEARCH
- Drug Combination Studies and Their Synergy Quantification Using the Chou-Talalay Method
- (2010) T.-C. Chou CANCER RESEARCH
- A Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell Subpopulations
- (2010) Sreenath V. Sharma et al. CELL
- Brain tumor stem cells: The cancer stem cell hypothesis writ large
- (2010) Peter B. Dirks Molecular Oncology
- MSH6 Mutations Arise in Glioblastomas during Temozolomide Therapy and Mediate Temozolomide Resistance
- (2009) S. Yip et al. CLINICAL CANCER RESEARCH
- Outcome prediction and risk assessment by quantitative pyrosequencing methylation analysis of the SFN gene in advanced stage, high-risk, neuroblastic tumor patients
- (2009) Barbara Banelli et al. INTERNATIONAL JOURNAL OF CANCER
- Different Response of Human Glioma Tumor-initiating Cells to Epidermal Growth Factor Receptor Kinase Inhibitors
- (2009) Fabrizio Griffero et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- NK Cells Recognize and Kill Human Glioblastoma Cells with Stem Cell-Like Properties
- (2009) R. Castriconi et al. JOURNAL OF IMMUNOLOGY
- Temozolomide Preferentially Depletes Cancer Stem Cells in Glioblastoma
- (2008) D. Beier et al. CANCER RESEARCH
- The emerging functions of histone demethylases
- (2008) Karl Agger et al. CURRENT OPINION IN GENETICS & DEVELOPMENT
- Erasing the methyl mark: histone demethylases at the center of cellular differentiation and disease
- (2008) P. A.C. Cloos et al. GENES & DEVELOPMENT
- Stem Cell–Related “Self-Renewal” Signature and High Epidermal Growth Factor Receptor Expression Associated With Resistance to Concomitant Chemoradiotherapy in Glioblastoma
- (2008) Anastasia Murat et al. JOURNAL OF CLINICAL ONCOLOGY
- SOX2Silencing in Glioblastoma Tumor-Initiating Cells Causes Stop of Proliferation and Loss of Tumorigenicity
- (2008) Rosaria Maria Rita Gangemi et al. STEM CELLS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started